Literature DB >> 20436077

Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis.

Daitaro Kurosaka1, Kenichiro Hirai, Makiko Nishioka, Yukio Miyamoto, Ken Yoshida, Kentaro Noda, Taro Ukichi, Maimi Yanagimachi, Kazuhiro Furuya, Eigo Takahashi, Isamu Kingetsu, Kunihiko Fukuda, Akio Yamada.   

Abstract

OBJECTIVE: To evaluate the clinical significance of serum levels of vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang-1), and angiopoietin-2 (Ang-2) in patients with rheumatoid arthritis (RA).
METHODS: The subjects were 70 patients with RA. Serum VEGF, Ang-1, and Ang-2 levels were determined by ELISA. As indices of disease activity, serum levels of C-reactive protein (CRP) and matrix metalloprotease (MMP)-3 were examined, and the 28-joint count Disease Activity Score (DAS28)-CRP was calculated. Power Doppler ultrasonography was performed in the bilateral wrists, elbows, shoulders, knees and ankles. The synovial blood flow signals were scored using a 3-grade scale (0-2), and the total of the scores in the 10 joints was regarded as the total signal score (TSS).
RESULTS: Serum VEGF level showed significant correlations with serum CRP and MMP-3 levels, DAS28-CRP, and TSS. Serum Ang-1 level showed significant correlations with serum MMP-3 level and DAS28-CRP. Serum Ang-2 level showed significant correlations with serum CRP level and TSS.
CONCLUSION: The serum VEGF level is important as an index of the activity of RA based on angiogenesis and a prognostic factor regarding joint destruction. Serum Ang-1 level may be useful as an index of sustained arthritis based on the maintenance of newly formed vessels. Serum Ang-2 level may reflect a state of marked angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20436077     DOI: 10.3899/jrheum.090941

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  27 in total

1.  Angiogenic growth factors in rheumatoid arthritis.

Authors:  Malte Schroeder; Lennart Viezens; Ina Fuhrhop; Wolfgang Rüther; Christian Schaefer; Britta Schwarzloh; Petra Algenstaedt; Bernd Fink; Nils Hansen-Algenstaedt
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

Review 2.  Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors:  Sofia Konisti; Serafim Kiriakidis; Ewa M Paleolog
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

3.  Neuropilin-1 is upregulated in Sjögren's syndrome and contributes to pathological neovascularization.

Authors:  Margherita Sisto; Sabrina Lisi; Dario Domenico Lofrumento; Massimo D'Amore; Domenico Ribatti
Journal:  Histochem Cell Biol       Date:  2012-01-12       Impact factor: 4.304

4.  Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases.

Authors:  Michail Kaklamanos; Dimitrios Thomas; Dimitrios Pikazis; Gregory Kaltsas
Journal:  Endocrine       Date:  2015-02-18       Impact factor: 3.633

5.  FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis.

Authors:  Menna R Clatworthy; Sarah K Harford; Rebeccah J Mathews; Kenneth G C Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-04       Impact factor: 11.205

6.  HIF-1A gene polymorphisms and its protein level in patients with rheumatoid arthritis: a case-control study.

Authors:  Agnieszka Paradowska-Gorycka; Barbara Stypinska; Andrzej Pawlik; Ewa Haladyj; Katarzyna Romanowska-Próchnicka; Marzena Olesinska
Journal:  Inflamm Res       Date:  2018-02-06       Impact factor: 4.575

Review 7.  Emerging role of semaphorin-3A in autoimmune diseases.

Authors:  Li-Na Liu; Xiao-Mei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammopharmacology       Date:  2018-04-25       Impact factor: 4.473

8.  Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.

Authors:  Jeffrey R Curtis; Annette H van der Helm-van Mil; Rachel Knevel; Tom W Huizinga; Douglas J Haney; Yijing Shen; Saroja Ramanujan; Guy Cavet; Michael Centola; Lyndal K Hesterberg; David Chernoff; Kerri Ford; Nancy A Shadick; Max Hamburger; Roy Fleischmann; Edward Keystone; Michael E Weinblatt
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

Review 9.  Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.

Authors:  Samar Masoumi Moghaddam; Afshin Amini; David L Morris; Mohammad H Pourgholami
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

10.  Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis.

Authors:  Shu Takagawa; Fumio Nakamura; Ken Kumagai; Yoji Nagashima; Yoshio Goshima; Tomoyuki Saito
Journal:  BMC Musculoskelet Disord       Date:  2013-01-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.